NORTH BRUNSWICK, N.J.--(BUSINESS WIRE)--Lactiga, a biotech company leading the development of naturally-occurring antibody therapies for inflammatory and immunodeficient conditions, has been ...

Under some circumstances, such as in immunodeficient people, C. albicans can cause invasive candidiasis – a severe and often ...